India News

Covid-19: SII's Covovax vaccine recommended for Phase 3 trial as booster dose in adults


The Pune-based SII had sought the permission from the DCGI to conduct Phase 3 study to evaluate the safety and immunogenicity of Covovax.

Leave a Reply

Your email address will not be published. Required fields are marked *